BI-1607
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


BI-1607
Target :
OthersRelated Pathways :
OthersBioactivity :
BI-1607 is a humanized monoclonal antibody targeting CD32b/Fc?RIIB. It acts as an antagonist, capable of blocking the inhibitory effects of Fc?RIIB on immune effector cells. When used in combination with Trastuzumab, BI-1607 can significantly suppress HER2-positive solid tumors, including advanced gastric cancer (GC) .Shipping Conditions :
Cool packStorage Temperature :
-20°C

